Board Appointment : Non-Execu

RNS Number : 2672E

Dechra Pharmaceuticals PLC

17 December 2009

 



Issued by Citigate Dewe Rogerson Ltd, Birmingham

Date: Thursday, 17 December 2009

Dechra® Pharmaceuticals PLC

("Dechra" or the "Company")

Board Appointment

Non-Executive Director

Dechra is pleased to announce the appointment of Bryan Morton as a Non-Executive Director with effect from 7 January 2010.

Bryan has a 30 year career in the pharmaceutical industry, largely with Merck & Co. Inc. and Bristol Myers Squibb where he has held positions of responsibility within marketing, sales, business development and general management.

In 2003 Bryan founded Zeneus Pharma, an oncology and critical care bio-pharmaceutical company which was sold in 2005.  Bryan is currently President and Chief Executive Officer of EUSA Pharma, a specialist pharmaceutical company focussing on oncology, pain control and critical care, which he founded in 2006.

Dechra's Chairman, Michael Redmond, said "The Board is delighted that Bryan has accepted the position of Non-Executive Director and we look forward to working with him to further strengthen Dechra's reputation as a leading international veterinary pharmaceutical business."

There are no other matters which require to be disclosed pursuant to paragraph 9.6.13R of the Listing Rules.

Enquiries:
Ian Page, Chief Executive	Fiona Tooley, Director
Dechra Pharmaceuticals PLC	Citigate Dewe Rogerson
Tel: [phone]	Tel: [phone]
Mobile: [phone] (IP)	Mobile: [phone] (FMT)
www.dechra.com
[e-mail]

Trademarks appear throughout this release in italics. Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC.

 

END

 

 

BOAGUGAGPUPBPUQ